In vivo CRISPR screening identified TP53 as a top tumor suppressor gene in immunocompetent WT mice but not in SCID immunodeficient mice using the 4T1 breast tumor syngeneic model, suggesting that loss of TP53 may contribute to evasion from the adaptive immune system [45]. This evidence concerns the gene TP53 and neoplasm.